4/A//SEC Filing
Stone Christopher Lewis 4/A
Accession 0000882104-20-000044
CIK 0000882104other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 8:46 AM ET
Size
5.1 KB
Accession
0000882104-20-000044
Insider Transaction Report
Form 4/AAmended
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common stock
2020-01-08+422,078→ 617,103 total
Footnotes (1)
- [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 8:46 AM ET
- Size
- 5.1 KB